Status:

COMPLETED

Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2

Lead Sponsor:

Wayne State University

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Marijuana Abuse

Eligibility:

All Genders

21-45 years

Brief Summary

The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating mari...

Detailed Description

Marijuana is the most commonly used illegal drug in the United States; more than 2 million Americans either abuse or are dependent on the drug. Therefore, there is a clear need for treatment options. ...

Eligibility Criteria

Inclusion

  • Meets DSM-IV diagnosis criteria for marijuana dependence
  • Able to read and write in English
  • Positive urine test for marijuana
  • If female, must be willing to use contraception throughout the study

Exclusion

  • Meets DSM-IV diagnosis criteria for a psychiatric illness
  • History of a psychotic disorder
  • Seeking treatment for marijuana dependence
  • Neurologic disease, including structural brain abnormalities (e.g., neoplasms), stroke, seizures, infectious disease, head trauma resulting in unconsciousness, or evidence of neurologic illness resulting from HIV/AIDS
  • Cardiovascular disease, including edema, chest pain or palpitations after exertion or drug use, myocardial infarction (heart attack), systolic blood pressure greater than 160 mm Hg or less than 95 mm Hg, or diastolic blood pressure greater than 95 mm Hg
  • Pulmonary disease, including apnea, cor pulmonale, tuberculosis, dyspnea, orthopnea, or tachypnea
  • Systemic disease, including endocrinopathies, kidney or liver failure, hypothyroidism, adrenocortical insufficiency, or autoimmune disease involving the central nervous system
  • Currently dependent on any drug other than marijuana or nicotine
  • Cognitively impaired
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

December 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2009

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00218504

Start Date

December 1 2005

End Date

October 1 2009

Last Update

June 5 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wayne State University

Detroit, Michigan, United States, 48207